NCT00006380View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2000

Primary Completion Date

March 31, 2002

Study Completion Date

March 31, 2002

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

monoclonal antibody muJ591

RADIATION

iodine I 131 monoclonal antibody muJ591

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00006380 - Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter